Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole
Document Type
Article
Date of Publication
9-21-2016
Publication Title
Journal of Clinical Oncology
First Page
3019
Last Page
3025
Recommended Citation
Ellis, M. J.; Tao, Y.; Young, O.; White, S.; Proia, A. D.; Murray, J.; Renshaw, L.; Faratian, D.; Dowsett, M.; Krause, A.; Evans, D. B.; Miller, W. R.; and Dixon, J. M., "Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole" (2016). Osteopathic Medicine, Jerry M. Wallace School of. 339.
https://cufind.campbell.edu/medicine_school/339
COinS
